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https://doi.org/10.1016/j.stemcr.2020.12.004SUMMARYAfter reprogramming to naive pluripotency, human pluripotent stem cells (PSCs) still exhibit very low ability to make interspecies chi-
meras. Whether this is because they are inherently devoid of the attributes of chimeric competency or because naive PSCs cannot colo-
nize embryos from distant species remains to be elucidated. Here, we have used different types of mouse, human, and rhesus monkey
naive PSCs and analyzed their ability to colonize rabbit and cynomolgusmonkey embryos. Mouse embryonic stem cells (ESCs) remained
mitotically active and efficiently colonized host embryos. In contrast, primate naive PSCs colonized host embryos with much lower ef-
ficiency. Unlikemouse ESCs, they slowedDNA replication after dissociation and, after injection into host embryos, they stalled in the G1
phase and differentiated prematurely, regardless of host species. We conclude that human and non-human primate naive PSCs do not
efficiently make chimeras because they are inherently unfit to remain mitotically active during colonization.INTRODUCTION
Human embryo-derived pluripotent stem cells (PSCs)
and human induced PSCs (iPSCs) exhibit biological and
functional characteristics of primed pluripotency: (1)
dependence on fibroblast growth factor 2 (FGF2)/extra-
cellular signal-regulated kinase and activin A/SMAD
signaling for self-renewal; (2) inactivation of the second
X chromosome in female lines; and (3) a global transcrip-
tome more similar to that of post-implantation epiblast
in the gastrulation embryo (Chen and Lai, 2015; David-
son et al., 2015; Nakamura et al., 2016; Nichols and
Smith, 2009). Although PSC lines obtained from rhesus
monkeys are less well characterized, they also exhibit
the essential characteristics of primed pluripotency
(Wianny et al., 2008). In this respect, human and non-
human primate PSCs differ from their murine counter-
parts, which exhibit biological and functional character-
istics of naive pluripotency (Chen and Lai, 2015; David-
son et al., 2015; Nichols and Smith, 2009). Notably,
naive and primed PSCs differ in their capacity to
generate chimeras following injection into pre-implanta-
tion embryos. Although mouse ESCs (mESCs) produce
germline chimeras, rhesus monkey PSCs do not colonize
the inner cell mass (ICM)/epiblast of the host embryo
and undergo apoptosis (Tachibana et al., 2012).56 Stem Cell Reports j Vol. 16 j 56–74 j January 12, 2021 j ª 2020 The Auth
This is an open access article under the CC BY license (http://creativecommoDifferent culturemedia with capacity to produce primed-
to-naive conversion of human, cynomolgus, and rhesus
macaque PSCs have been reported. Themedia are variously
termed naive human stem cell medium (NHSM) (Gafni
et al., 2013), E-NHSM (https://hannalabweb.weizmann.
ac.il), NHSM-v (Chen et al., 2015b), 3iL (Chan et al.,
2013), Reset (Takashima et al., 2014), 5i/L/A and 6i/L/A
(Theunissen et al., 2014, 2016), 4i/L/b (Fang et al., 2014),
TL2i (Chen et al., 2015a), 2iLD, 4i, and FAC (Wu et al.,
2017), t2iLGöY (Guo et al., 2017), and LCDM (Yang et al.,
2017b). PSCs under these culture conditions display char-
acteristic features of naive-state pluripotency of mESCs
with a reconfigured transcriptome and epigenome (Chen
et al., 2015a; Huang et al., 2014; Nakamura et al., 2016),
loss of FGF2 dependency (Chen et al., 2015a; Takashima
et al., 2014), gain of STAT3 dependency (Chan et al.,
2013; Chen et al., 2015a; Gafni et al., 2013; Takashima
et al., 2014), reactivation of the second X chromosome
(Fang et al., 2014; Takashima et al., 2014; Theunissen
et al., 2014), and elevation of oxidative phosphorylation
(Takashima et al., 2014; Ware et al., 2009).
Colonization of mouse embryos by human naive PSCs
and their subsequent participation in germ layer differenti-
ation has been reported (Fang et al., 2014; Gafni et al.,
2013). However, these early results were not confirmed by
subsequent reports: low rates of chimerism (<0.001%) inor(s).
ns.org/licenses/by/4.0/).
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Figure 1. Colonization of Rabbit and Cynomolgus Embryos by mESCs
(A) Epifluorescence images of the early- (E3, 1 DIV) and mid-blastocyst-stage rabbit embryos (E4, 2 DIV) resulting from microinjection of
10 mESC-GFP cells. Scale bars, 50 mm.
(B) Two-photon microscope images of the late blastocyst-stage rabbit embryos (E2–E5, 0–3 DIV) resulting frommicroinjection of 10 mESC-
GFP cells. Scale bars, 50 mm.
(C) Immunostaining of GFP and EdU in a late blastocyst-stage rabbit embryo (E5, 3 DIV) after microinjection of 10 mESC-GFP cells into the
morula-stage (E2) embryo (confocal imaging). Scale bar, 50 mm.
(D) Immunostaining of GFP, OCT4, SOX2, NANOG, and SOX17 of late blastocyst-stage rabbit embryos (E5, 3 DIV) after microinjection of 10
mESC-GFP cells into morula-stage (E2) embryos (confocal imaging; n = 135). Scale bars, 50 mm.
(legend continued on next page)
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<1% of the fetuses were reported after injection of human
naive PSCs in mouse blastocysts (Masaki et al., 2015; Theu-
nissen et al., 2016). Similarly, very low rates of chimerism
were also observed in pig fetuses after injecting human
naive iPSCs in pig embryos (Wu et al., 2017). Whether hu-
man PSCs have failed to produce chimeras because naive
PSCs in general cannot colonize embryos from distant spe-
cies or because human PSCs are inherently devoid of the at-
tributes of chimeric competence is not known.
To explore this issue, we investigated the differential abil-
ity of mESCs, and rhesus monkey and human naive PSCs,
to colonize both closely and distantly related host
embryos. To circumvent the ban on introducing human
embryo-derived PSCs into animal embryos, we used em-
bryo-derived rhesus monkey PSCs and human iPSCs. As a
reference, we explored the ability of mESCs, the gold stan-
dard of naive pluripotency, to colonize evolutionary
distant host embryos. As host species, we selected rabbit
and cynomolgus monkey embryos. Primates and glires (ro-
dents + lagomorphs) diverged between 85 and 97 million
years ago, while rodents and lagomorphs diverged between
77 and 88million years ago (www.timetree.org). The diver-
gence time makes rabbit embryos an almost equidistant
environment for comparing the colonizing capabilities of
rodent and primate PSCs. In addition, rabbits have several
advantages in testing the colonization capacity of human
PSCs. The early rabbit embryos share common features
with primate embryos in their developmental characteris-
tics (Madeja et al., 2019); unlike the three-dimensional
egg-cylinder shape of rodent embryos during gastrulation,
primate and rabbit embryos develop into a flattened disc at
the surface of the conceptus; primate and rabbit embryos
are also markedly similar with respect to the timing of zy-
gotic genome activation and the timing and regulation of
X chromosome inactivation. In rodents and primates,
gastrulation occurs in the implanted embryo buried within
the uterine wall. However, in rabbits, gastrulation begins
shortly before implantation, allowing easier access to a
wider developmental window. Furthermore, the rabbit
PSC lines derived from pre-implantation embryos require
FGF2 and transforming growth factor b for inhibition of
differentiation and exhibit the cardinal features of primed
pluripotency (Osteil et al., 2013, 2016). Thus, rabbit pre-
implantation embryos appear to bemore similar to primate
embryos than mouse embryos with respect to the mecha-
nisms regulating pluripotency. Therefore, they may be a
better host for examining the colonization competence
of human PSCs. As a closely related host for human and
rhesus monkey PSCs, we used cynomolgus macaque em-(E) Histogram of percentage of rabbit embryos with GFP+/OCT4+, GFP
(F) Immunostaining of GFP, OCT4, SOX2, and SOX17 of late blastocyst-s
cells into morula-stage (E4) embryos (confocal imaging; n = 7). Scale
58 Stem Cell Reports j Vol. 16 j 56–74 j January 12, 2021bryos. The common ancestor of macaques and humans
dates back 29 million years, while rhesus and cynomolgus
macaques diverged 3.7 million year ago (http://www.
timetree.org). We explored the differential ability of
mESCs, rhesus monkey PSCs, and human naive iPSCs to
colonize rabbit and cynomolgus embryos, and drew con-
clusions on the inherent abilities of rodent and primate
naive PSCs to colonize distantly related hosts.RESULTS
Colonization of Rabbit Embryos by mESCs
Fresh rabbit embryos observed by epifluorescence micro-
scopy typically show a high level of autofluorescence (Fig-
ure S1A), which could be confounding for the detection of
GFP-expressing cells in chimeras. To overcome this limita-
tion, we systematically used an anti-GFP antibody. No im-
munostaining was observed when applied to rabbit em-
bryos (1) before any injection of cells, and (2) after
injection of ten rhesus wild-type PSCs (LyonES [Wianny
et al., 2008]) that do not express any fluorescent reporters.
Immunolabeling was observed in both rhesus PSCs ex-
pressing GFP as a fusion between tau protein and GFP
(LyonES-tauGFP) (Figure S1B) and rabbit embryos colo-
nized with naive-like rabbit iPSCs expressing GFP (Fig-
ure S1C) (Osteil et al., 2016). Thus, immunolabeling of
GFP allows an effective detection of GFP expression in
our system.
Mouse ESCs grown in serum/leukemia inhibitory factor
(LIF) and, in particular, in 2i/LIF epitomize naive pluripo-
tency and, for this reason, we tested their ability to colonize
rabbit embryos. For this purpose, ten mESC-GFP cells
cultured in serum/LIF condition were injected into rabbit
embryos at the morula stage (embryonic day 2 [E2]). The
morulas were subsequently cultured for 1–3 days in vitro
(DIV) and developed into early (E3), mid (E4), and late
(E5) blastocysts (1, 2, and 3 DIV, respectively). The vast ma-
jority of rabbit blastocysts had incorporated groups of GFP+
cells (97.5%, n = 81) (Figure 1A; Table S1). mESCs and their
progeny divided very actively, as shown by both the expan-
sion of the GFP+ cell pool during in vitro culture of chimeric
embryos and a high incorporation of 5-ethylnyl-20-deoxy-
uridine (EdU) in most GFP+ cells (Figures 1B and 1C; Video
S1). It should be noted that, under the conditions used
(very short incorporation time), the EdU labeling of host
embryo cells is markedly low. GFP+ cells and their progeny
expressed the transcription factors and pluripotency
markers OCT4, NANOG, and SRY-box transcription factor+/SOX2+, GFP+/NANOG+, and GFP+/SOX17+ cells at 3 DIV (n = 74).
tage (E7) cynomolgus embryos after microinjection of 10 mESC-GFP
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(SOX)2, as revealed by immunostaining at E5 (3 DIV) (Fig-
ures 1D and 1E). In contrast, GFP+ cells did not express
SOX17, a primitive endoderm marker, indicating that
they did not differentiate to the primitive endoderm line-
age. We performed a similar experiment using cynomolgus
monkey embryos as hosts. For this purpose, 10 mESC-GFP
cells were injected into cynomolgus embryos at the morula
stage (E4). The morulas were subsequently cultured for 3
DIVand developed intomid/late (E7) blastocysts before im-
munostaining with GFP, OCT4, NANOG, SOX2, and
SOX17 antibodies. Among the 5 embryos analyzed, 3 con-
tained 8–16 GFP+ cells in the ICM. The first embryo was
immunostained with GFP, OCT4, and SOX2 antibodies
and contained 16 GFP+/OCT4+/SOX2+ cells. The second
one was immunostained with GFP and NANOG antibodies
and contained eight GFP+/NANOG+ cells. The third one
was immunostained with GFP and SOX17 antibodies and
contained eight GFP+/SOX17 cells (Figure 1F; Table S1).
In another experiment, ten mESC-GFP cells propagated
in N2B27 supplemented with LIF, PD0325901, and
CHIR99021 (i.e., 2i/LIF condition) were injected into rabbit
morulas and subsequently cultured for 3 DIV before immu-
nostaining (Figure S2A and Table S1). Of the 19 E5 blasto-
cysts obtained, 14 had incorporated groups of GFP+ cells.
Immunostaining showed that 100% of chimeric embryos
harbored GFP+ cells expressing SOX2 (n = 7/7), whereas
none of them expressed SOX17 (n = 0/7). Overall, these re-
sults show thatmESCs, whether in serum/LIF or 2i/LIF con-
ditions, continue to express pluripotency markers and
expand after injection into evolutionary distant embryos,
whether rabbit or cynomolgus monkey embryos.
We subsequently studied the ability ofmESCs to colonize
the embryonic disk of rabbit pre-gastrula embryos (E6) and
the three germ layers after gastrulation (E9). For this pur-
pose, the E2 embryos injected with 10 mESC-GFP cells
(grown in serum/LIF) were transferred into the oviducts
of surrogate rabbits. Nine embryos were recovered after
4 days (i.e., E6). All contained GFP+ cells expressing OCT4
and SOX2 (Figure S2B and Table S1). Three embryos wereFigure 2. Characterization of Rhesus PSCs after Reprogramming t
(A) Phase contrast and immunostaining of naive pluripotency markers
rhesus PSCs) and after reprogramming to the naive state (E-NHSM, NHS
imaging). Scale bars, 50 mm.
(B) Immunostaining of 50-methylcytosine (5mC), 50-hydroxymethylcyt
LyonES-tGFP-(S3) cells, before (primed) and after reprogramming to th
bars, 50 mm.
(C) Activity of the proximal and distal enhancers (PE and DE, respect
fection in primed PSCs, E-NHSM, NHSM-v, 4i/L/b, TL2i, t2iLGöY, and
(D) Principal-component analysis (PCA) for primed PSCs, E-NHSM, NH
based on RNA sequencing (RNA-seq) data.
(E) PCA for primed PSCs, E-NHSM, NHSM-v, 4i/L/b, TL2i, t2iLGöY, LCD
cell RNA-seq data of cynomolgus epiblast from E6 to E9 embryos (Na
60 Stem Cell Reports j Vol. 16 j 56–74 j January 12, 2021immunostained with a SOX17 antibody and did not
show SOX17+ cells. On the other hand, the GFP+ cells
formed a coherent group of cells in the embryonic disk,
suggesting that mouse cells did not mix with rabbit cells.
To assess whether mESCs participated in the development
of rabbit embryos after gastrulation, 20 fetuses were recov-
ered 7 days after transfer to surrogatemothers (i.e., E9) (Fig-
ure S2C and Table S1). Fetuses contained GFP+/SOX2+,
GFP+/TUJ1+, and GFP+/NANOG cells in the neurectoderm
(n = 12/12). None of the fetuses had GFP+ cells in embry-
onic tissues derived from the mesoderm and endoderm or
in extra-embryonic tissues. These results strongly suggest
that mESCs injected into rabbit morulas contribute to the
expansion of the late epiblasts until the onset of gastrula-
tion. After gastrulation, mESCs were able to contribute to
the neuroectoderm, but not to other embryonic and ex-
tra-embryonic lineages.
Reprogramming Rhesus PSCs to Naive Pluripotency
The LyonES rhesus line expressing a tauGFP transgene un-
der the control of the ubiquitous CAG promoter has been
described previously (Wianny et al., 2008). LyonES-
tauGFP cells were infected with the pGAE-STAT3-ERT2 len-
tiviral vector (Chen et al., 2015a), and a clonal cell line
stably expressing STAT3-ERT2 was isolated as LyonES-
tGFP-(S3). Immunostaining with anti-STAT3 antibody
showed increased labeling and nuclear translocation
following the treatment of LyonES-tGFP-(S3) cells with
tamoxifen (Figure S3A). LyonES-tGFP-(S3) cells were
cultured in the presence of tamoxifen to activate STAT3-
ERT2 and with 1,000 U/mL of LIF, MEK, and GSK3b inhib-
itors. Consistent with previous observations in human
PSCs (Chen et al., 2015a), the LyonES-tGFP-(S3) cells
formed small dome-shaped colonies, which were termed
rhesus TL2i (rhTL2i) cells (Figure 2A). These colonies
demonstrated identical morphology with that described
previously for human TL2i cells (Chen et al., 2015a). We
developed a variant of the TL2i protocol, in which MEKi
and GSK3bi were replaced by CNIO-47799, a chemicalo Naive Pluripotency
, TFAP2C, KLF4, and TFE3 in LyonES-tGFP-(S3) cells, before (primed
M-v, 4i/L/b, TL2i, t2iLGöY, LCDM (EPS), and TL-CDK8/19i) (confocal
osine (5hmC), H3K4me3, H3K9me3, H2AK119Ub, and H3K27me3 in
e naive state (4i/L/b, TL2i, and t2iLGöY) (confocal imaging). Scale
ively) of OCT4 measured in a luciferase assay after transient trans-
LCDM cells.
SM-v, 4i/L/b, TL2i, t2iLGöY, LCDM, and TL-CDK8/19i populations
M, and TL-CDK8/19i populations based on bulk RNA-seq and single-
kamura et al., 2016).
inhibitor of cyclin-dependent kinases (CDK)8 and CDK19
(CDK8/19i) for reprogramming to the naive state (Lynch
et al., 2020). This protocol is referred to as TL-CDK8/19i
and the reprogrammed cells as rhesus TL-CDK8/19i
(rhTL-CDK8/19i). LyonES-tGFP-(S3) cells were submitted
to six other reprogramming protocols previously devel-
oped to revert human or monkey PSCs to naive pluripo-
tency, including NHSM-v and E-NHSM (Chen et al.,
2015b; Gafni et al., 2013), 4i/L/b (Fang et al., 2014), t2iL-
GöY (Guo et al., 2016; Takashima et al., 2014), 5iL/A or
6iL/A (Theunissen et al., 2014), and LCDM (extended
pluripotent stem [EPS]) (Yang et al., 2017b). It should be
noted that the six protocols were applied to LyonES-
tGFP-(S3) cells in the absence of tamoxifen, thus main-
taining STAT3-ERT2 in an inactive state. LyonES-tGFP-
(S3) cells differentiated or underwent apoptosis when
cultured in LIF/MEKi/GSK3bi (not shown). Of the eight
protocols tested, seven (i.e., NHSM-v, E-NHSM, 4i/L/b,
t2iLGöY, LCDM [EPS], TL2i, and TL-CDK8/19i) produced
rhesus PSCs forming dome-shaped colonies (Figure 2A).
Continued instability was observed with protocol 5iL/A,
which was subsequently omitted from the study. Unlike
conventional rhesus PSCs, which were mechanically
passaged in clumps, all reprogrammed cells were routinely
dissociated into single cells using trypsin or trypLE. The
colonies exhibited variable expression of naive transcrip-
tion factors and cell surface molecules (Figures 2A, S3B
and, S3G). Notably, the transcription factors AP-2 gamma
(TFAP2C), KLF4, and transcription factor binding to
IGHM enhancer 3 (TFE3) displayed stronger expression af-
ter reprogramming using the 4i/L/b, t2iLGöY, TL2i, and
TL-CDK8/19i protocols. LCDM (EPS) cells expressed
KLF4 and TFE3 but not TFAP2C. Cells reprogrammed
with the other protocols did not express any of these
naive markers (TFAP2C, KLF4, and TFE3). t2iLGöY, TL2i,
and 4i/L/b cells featured lower levels of H3K4me3 marks
(Figures 2B and S3C–D). They also displayed diffuse
H3K27me3 immunostaining compared with punctate
staining in primed, NHSM-v, and E-NHSM cells (Figures
2B, S3C, and S3E). Immunostaining of 50-methylcytosine
and 50-hydroxymethylcytosine also revealed global
genome hypomethylation in t2iLGöY, LCDM (EPS), and
TL2i cells (Figures 2B, S3C, and S3D). Primed, E-NHSM,
and NHSM-v cells exhibited punctate immunostaining
for H2AK119Ub, indicating the presence of an inactive
X chromosome, whereas t2iLGöY, LCDM (EPS), TL2i,
and 4i/L/b cells displayed diffuse immunostaining, sug-
gesting X chromosome reactivation (Figures 2B, S3C,
and S3E). Altogether, these results strongly suggest that
t2iLGöY, LCDM (EPS), TL2i, and 4i/L/b cells underwent
epigenome reconfiguration, in line with the results of
naive marker expression. Finally, consistent with their
naive status, t2iLGöY, TL2i, and 4i/L/b cells exhibitedpreferential usage of the distal enhancer of Oct4 in a lucif-
erase assay (Figure 2C).
To further characterize reprogramming, gene expression
was analyzed by bulk RNA sequencing to assess transcrip-
tome reconfiguration. Principal-component analysis and
hierarchical clustering showed that primed and E-NHSM
cells clustered on one side, whereas NHSM-v, 4i/L/b, t2iL-
GöY, TL2i, and LCDM (EPS) cells clustered on the other
side (Figure 2D; Figure S3F and Table S2). TL-CDK8/19i cells
demonstrated an intermediate position, suggesting that
transcriptome reconfiguration was less pronounced. A
comparative analysis was performed between the primed
and naive rhesus PSC lines and single-cell RNA sequencing
data of the cynomolgus epiblast (Nakamura et al., 2016).
The NHSM-v, 4i/L/b, t2iLGöY, TL2i, and LCDM (EPS) cells
also clustered closer to the epiblast cells of the E6/E7 cyno-
molgus embryo (Nakamura et al., 2016) than the E-NHSM
and primed cells (Figure 2E). These results show that,
consistent with the immunostaining data, reprogramming
of rhesus PSCs is characterized by a transcriptome shift re-
flecting the acquisition of characteristic features of the pre-
implantation epiblast as reported previously with human
naive PSCs (Nakamura et al., 2016).
Premature Differentiation of Rhesus Naive PSCs after
Injection into Rabbit Embryos
The ability of reprogrammed rhesus PSCs to colonize rabbit
ICM/epiblast was tested. For this purpose, ten LyonES-
tGFP-(S3) cells of each type (primed, NHSM-v, E-NHSM,
LCDM [EPS], 4i/L/b, t2iLGöY, TL2i, and TL-CDK8/19i)
were injected into rabbit morulas (E2). The embryos were
subsequently cultured for 1–3 DIV in gradual medium
and developed into early (E3),mid (E4), and late blastocysts
(E5). There was no difference observed in the rate of devel-
opment between control (uninjected) and injected em-
bryos (not shown). In the first set of experiments, the fate
of injected cells was monitored by two-photonmicroscopy
for 48–72 h. Contrary to our observations withmESCs, rhe-
sus PSCs did not actively proliferate in host embryos, and
most of them did not incorporate into ICM/epiblast
(Videos S2, S3, S4, and S5). GFP+ embryos and cell counts
confirmed this finding: the number of embryos with
GFP+ cells decreased with time in culture, ranging from
0% (E-NHSM) to 62% (t2iLGöY) at 3 DIV compared with
22%–96% at 1 DIV (Figure 3A; Table S1). In addition, the
percentage of embryos with R4 GFP+ cells diminished in
all experimental conditions tested, ranging from 0%
(E-NHSM) to 24% (TL2i) at 3 DIV versus 0% (E-NHSM) to
79% (t2iLGöY) at 1 DIV (Figure 3B). These results indicate
that rhesus PSCs failed to actively divide and/or were grad-
ually eliminated during embryonic development, regard-
less of the reprogramming strategy used for conversion to
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thrive in a rabbit embryo environment, variations in the
survival rate of GFP+ cells at 3 DIV were observed between
reprogramming strategies. There were no GFP+ cells
observed in embryos injected with either primed rhesus
PSCs (0/90) or E-NHSM cells (0/71). In contrast, GFP+ cells
were observed at varying frequencies using other reprog-
ramming protocols. At 3 DIV, the highest rates were
observed with TL2i (57%, n = 490), 4i/L/b (41%, n = 228),
t2iLGöY (37%, n = 168), LCDM (26%, n = 335), and TL-
CDK8/19i (20%, n = 260). TL2i was the only reprogram-
ming method that returned more GFP+ cells at 2 DIV
(58%, n = 145) and 3 DIV (57%, n = 204) compared with
1DIV (44%, n = 141). These results suggested that TL2i cells
have a slightly increased proliferative capacity compared
with cells reprogrammed using other methods (Figure 3B).
We subsequently characterized the surviving rhesus
PSCs. The chimeric embryos were immunostained with
GFP, OCT4, SOX2, NANOG, and GATA6 antibodies at E3
(1 DIV, 335 embryos with GFP+ cells, n = 650), E4 (2 DIV,
202 embryos with GFP+ cells, n = 664), and E5 (3 DIV,
217 embryos with GFP+ cells, n = 932). GFP+/OCT4+ and
GFP+/GATA6+ co-immunostaining was frequently
observed in chimeric embryos at 3 DIV. In contrast, GFP+/
SOX2+ cells were rarely observed (Figure 3C; Table S1).
GFP+/SOX2+, GFP+/NANOG+, and GFP+/GATA6+ cells
were counted in 754 positive embryos. A strong decrease
in the rate of GFP+/SOX2+ and GFP+/NANOG+ cells and
an increase in the rate of GFP+/GATA6+ cells were observed
between 1 and 3 DIV with all reprogramming protocols
(Figure 3D). These results strongly suggest that the vast ma-
jority of rhesus PSCs abolished the expression of pluripo-
tency markers and committed prematurely to differentia-
tion after injection into rabbit embryos. A similar result
was observed when rabbit embryos injected with TL2i rhe-
sus PSCs were cultured for 3 days in gradual medium sup-
plementedwith 250 nM tamoxifen (Figure S4A), indicating
that the maintenance of high STAT3 activity is not suffi-
cient to overcome the spontaneous differentiation that oc-
curs during embryo colonization.
In previous experiments, we compared the colonization
capabilities of mESCs and monkey PSCs using the same
experimental paradigm, which included single-cell dissoci-
ation and embryo culture in 20%O2 concentration. RabbitFigure 3. Colonization of Rabbit Embryos by Rhesus Naive PSCs
(A) Percentage of rabbit embryos with GFP+ cells, 1–3 days (1–3 DIV)
(E2) embryos, before (primed) and after reprogramming to the naive
CDK8/19i) (n = 650 at 1 DIV; n = 664 at 2 DIV; n = 932 at 3 DIV).
(B) Percentage of rabbit embryos with 0, 1, 2, 3, or >3 GFP+ cells 1–3
morula-stage (E2) embryos (n = 650 at 1 DIV; n = 664 at 2 DIV; n = 9
(C) Immunostaining of GFP, OCT4, SOX2, and GATA6 in late blastoc
(confocal imaging). Scale bars, 50 mm.
(D) Percentage of GFP+/NANOG+, GFP+/SOX2+, and GFP+/GATA6+ cellsembryos are routinely cultured at atmospheric O2 concen-
tration (Tapponnier et al., 2017). Thus, we compared the
GFP+ cell colonization rates after culturing host embryos
under normoxic (20% O2) and hypoxic (5% O2) condi-
tions. Following injection of 10 rhesus TL2i cells, host em-
bryos were cultured under conditions of 5% and 20% O2
concentration (number of embryos treated: 112 and 109,
respectively). The rate of embryos containing GFP+ cells
was lower at 1, 2, and 3 DIV after culture at 5% O2 concen-
tration (Figure S4B).We also evaluatedwhethermicroinjec-
tion of cell clumps into rabbit embryos would improve the
colonization capabilities compared with single-cell suspen-
sions. The experiment was performed using rhesus TL2i
cells. At both 1 and 2 DIV, the rate of GFP+ embryos ob-
tained after injection of small aggregates of 10 cells was
lower than that obtained after injection of the same num-
ber of isolated cells (1 DIV: 37% versus 53%, respectively;
n = 76; 2 DIV: 19% versus 43%, respectively; n = 76; Fig-
ure S4C). In contrast, at 3 DIV, injection of aggregates of
10 cells yielded slightly better results than those
recorded after injection of the same number of isolated
cells (18.9% versus 6.25% of GFP+ embryos, respectively;
n = 98). However, we did not observe an increase in the
number of GFP+ cells in the positive embryos. Finally, we
evaluated the efficacy of colonization after microinjection
of ten cells into embryos at themorula stage (E2) compared
with the blastocyst stage (E4) (Figure S4D). At 3 DIV, we
observed lower levels of GFP+ embryos for TL2i cells (39%
versus 6%) and 4i/L/b cells (29% versus 0%) after microin-
jection into blastocyst-stage embryos. On the basis of these
additional experiments, we concluded that injection of
embryos at the blastocyst stage, injection of cell clumps,
and reduction of O2 concentration during embryo culture
had no measurable effects on the rate of embryo coloniza-
tion by rhesus PSCs.
Previous studies have shown that inhibiting apoptosis
either by the addition of the ROCK inhibitor Y27632
(Kang et al., 2018), or by overexpression of the anti-
apoptotic genes BCL2 (Masaki et al., 2016) or BMI1 (Huang
et al., 2018), enables primed PSCs to colonize host em-
bryos. Therefore, in a final series of microinjections, we
asked whether inhibition of apoptosis could improve the
engraftment of naive PSCs into the host embryo. Forafter injection of rhesus LyonES-tGFP-(S3) cells into morula-stage
state (E-NHSM, NHSM-v, 4i/L/b, TL2i, t2iLGöY, LCDM (EPS), and TL-
days (1–3 DIV) after injection of rhesus LyonES-tGFP-(S3) cells into
32 at 3 DIV).
yst-stage (E5) rabbit embryos after microinjection of rhesus PSCs
in rabbit embryos 1–3 days after injection of rhesus PSCs (n = 232).
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this purpose, NHSM-v and t2iLGöY PSCs were treated with
the ROCK inhibitor during dissociation and microinjec-
tion into the host embryos. The rates of embryos contain-
ing GFP+ cells were similar at all three time points analyzed
(1, 2, and 3DIV; Figure S4E). Thus, addition of ROCK inhib-
itor did not improve the rate of embryo colonization by
rhesus naive PSCs.
Colonization of Rabbit Pre-implantation Embryos by
Human iPSCs
We subsequently investigated whether human naive PSCs
exhibited a similar behavior to that of rhesus naive PSCs af-
ter injection into rabbit embryos. We tested the coloniza-
tion capabilities of two human iPSC lines, cR-NCRM2
(Guo et al., 2017) and IR1.7 (Ng et al., 2012), after reprog-
ramming with t2iLGöY (Guo et al., 2017) and TL2i proto-
cols (Chen et al., 2015a), respectively. The cR-NCRM2-t2iL-
GöY cells express the naive pluripotency markers TFAP2C,
KLF4, KLF17, transcription factor CP2-like 1 (TFCP2L1),
and sushi domain containing 2 (SUSD2) (Bredenkamp
et al., 2019) (Figure S4F). After injection into rabbit mor-
ulas, immunofluorescencewas used for the detection of hu-
man nuclear antigen (HuN) to trace human cells in rabbit
host embryos. On days 1, 2, and 3, 93% (n = 29), 65%
(n = 31), and 33% (n = 130) of the embryos contained
HuN+ cells in the ICM/epiblast, respectively (Figure 4C; Ta-
ble S1). At 3 DIV, double immunofluorescence analysis re-
vealed that 45% (n = 12), 17% (n = 13), and 32% (n = 6)
of the embryos contained HuN+/SOX2+, HuN+/NANOG+,
and HuN+/GATA6+ cells, respectively (Figures 4A and 4D).
These rates are similar to those obtained previously using
t2iLGöY rhesus PSCs (Figure 3B), suggesting extremely
similar colonization capabilities for rhesus and human
t2iLGöY cells. Chimeric embryos also contained HuN+/
SOX17+ (50%, n = 30) and HuN+/T-BRA+ cells (36%, n =
30), but none of the embryos examined contained HuN+/
NESTIN+ cells (n = 30), suggesting preferential differentia-
tion toward mesodermal and endodermal lineages (Figures
4A and 4D). Similar results were obtained using naive
IR1.7-TL2i cells. These cells have been described previously
(Chen et al., 2015a) (Figure S4F). On days 1, 2, and 3, 85%
(n = 39), 50% (n = 36), and 28% (n = 39) of embryos, respec-
tively, contained HuN+ cells in the ICM/epiblast (Figure 4C
and Table S1). At 3 DIV, chimeric embryos contained
HuN+/SOX2+ (10%, n = 76), HuN+/GATA6+ (36%, n = 70),
and HuN+/SOX17+ (86%, n = 30) cells (Figures 4B and
4D). None of the embryos examined contained HuN+/
NANOG+ (n = 26), HuN+/T-BRA+ (n = 27), and HuN+/NES-
TIN+ (n = 30) cells. Considering all of the data obtained us-
ing both cR-NCRM2-t2iLGöY and IR1.7-TL2i cells, donor
cells that colonized rabbit embryos expressed SOX2 (21%,
n = 30), NANOG (8%, n = 5), GATA6 (32%, n = 33),
SOX17 (58%, n = 35), and T-BRA (19%, n = 11) (Figure 4E).64 Stem Cell Reports j Vol. 16 j 56–74 j January 12, 2021These results illustrated both a low rate of colonization by
SOX2+/NANOG+/OCT4+ human naive PSCs at 3 DIV and
premature differentiation of the donor cells to endodermal
and mesodermal fates, thus confirming and extending the
results obtained using rhesus naive PSCs.
We then asked whether the inhibition of apoptosis via
overexpression of the anti-apoptotic gene BCL2 (Masaki
et al., 2016) could improve the engraftment of human
naive iPSCs and prevent their premature differentiation.
Both cR-NCRM2-t2iLGöY and IR1.7-TL2i cells were trans-
fectedwith doxycycline (Dox)-inducible humanBCL2. Sta-
ble transfectants expressing BCL2 in response to Dox were
selected in neomycin (hereafter called cR-NCRM2-t2iL-
GöY-BCL2i and IR1.7-TL2i-BCL2i cells; Figure S4G) and
subsequently injected into rabbit morulas before culture
for 3 DIV in Dox- or vehicle (control)-supplemented
gradual medium. In Dox-supplemented medium, 100%
(n = 82) and 81% (n = 76) of the embryos injected with
cR-NCRM2-t2iLGöY-BCL2i and IR1.7-TL2i-BCL2i cells,
respectively, exhibited the presence of HuN+ cells in the
ICM/epiblast stage, whereas these rates were only 30%
(n = 66, p < 0.001, c2 test) and 34% (n = 77, p < 0.001, c2
test), respectively, for control cells (Figure 4F and Table
S1). Moreover, at 3 DIV, the Dox-induced embryos con-
tained more HuN+ cells than the control embryos (Dox:
3.3 ± 1.55 cells/embryo; +Dox: 18.7 ± 5.5 cells/embryo;
p < 0.001, Student’s t test; Figures 4H and 4I). These results
strongly suggest that BCL2 overexpression prevents donor
cell death after embryo injection. It should be noted that
the percentage of EdU+ cells was not altered (Dox: 16%
[n = 20]; +Dox: 13% [n = 20]; p < 0.69, c2 test; Figures 4G
and S4H), indicating that BCL2 overexpression had no
measurable effect on the mitotic index of the donor cells.
The identity of the surviving HuN+ cells was subsequently
analyzed via double immunofluorescence at 3 DIV. In
the +Dox condition, most embryos contained HuN+/
GATA6+ cells, suggesting that BCL2 overexpression does
not alter the natural propensity of donor cells to differen-
tiate after injection into host embryos (Figures 4G–4I). To
eliminate the confounding effect of the higher HuN+ cell
count observed in Dox-treated embryos, we counted the
number of HuN+ cells expressing SOX2, NANOG, and
GATA6 in both induced (+Dox; n = 144) and uninduced
embryos (Dox; n = 143). The proportions of HuN+/
GATA6+ cells were strongly diminished after BCL2 induc-
tion (2% [n = 27] versus 31% [n = 20] for cR-NCRM2-t2iL-
GöY-BCL2i cells, p < 0.001, c2 test; 17% [n = 25] versus
57% [n = 25] for IR1.7-TL2i-BCL2i cells, p < 0.001, c2
test). However, the sharp decrease in the proportion of
HuN+/GATA6+ cells was not associated with mirror
increases in the proportions of HuN+/NANOG+ (19.5%
[n = 27] versus 20% [n = 26] for cR-NCRM2-t2iLGöY-
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both + Dox and Dox conditions) and HuN+/SOX2+ cells
(13% [n = 25] in both + Dox and Dox conditions). On
the contrary, it was strongly diminished in cR-NCRM2-
t2iLGöY-BCL2i cells (0% [n = 28] versus 58% [n = 20], p <
0.001, c2 test). Thus, BCL2 overexpression significantly
increased the efficiency of embryo colonization by human
naive PSCs. However, in most of the examined embryos,
the vast majority of the donor cells failed to maintain the
expression of pluripotency markers, and many of them re-
mained unspecified or expressed GATA6.Colonization of Cynomolgus Monkey Pre-
implantation Embryos by Rhesus PSCs and Human
iPSCs
We questioned whether the low rate of proliferation and
ICM/epiblast colonization of human TL2i and t2iLGöY
cells after injection into rabbit morulas were due to the
evolutionary distance between the two species. To answer
this question, we injected human cR-NCRM2-t2iLGöY
and IR1.7-TL2i cells, and rhesus TL2i cells, into cynomol-
gus monkey embryos. Ten cells of each were injected into
embryos at the morula stage (E4). The embryos were subse-
quently cultured for 3 DIV in gradual medium and devel-
oped into mid/late (E7) blastocysts before being subjected
to triple immunostaining for GFP, OCT4, and NANOG.
Of the 29 cynomolgus embryos, 13% (n = 15) had incorpo-
rated human cR-NCRM2-t2iLGöY cells, for a total of 5 GFP+
cells (2 and 3 GFP+ cells/embryo), of which only 1 was both
OCT4+ and NANOG+ (Figure 5A; Table S1); 29% (n = 7) of
the cynomolgus embryos had incorporated human IR1.7-
TL2i cells, for a total of 14 GFP+ cells (10 and 4 GFP+
cells/embryo), of which 2 were either OCT4+ or NANOG+
(Figure 5B; Table S1); and 29% (n = 7) of cynomolgus em-Figure 4. Colonization of Rabbit Embryos by Human Naive PSCs
(A) Immunostaining of HuN, SOX2, NANOG, GATA6, SOX17, and T-BR
injection of cR-NCRM2-t2iLGöY cells into morula-stage (E2) embryos
(B) Immunostaining of HuN, SOX2, NANOG, GATA6, OCT4, and SOX17
jection of IR7.1-TL2i cells into morula-stage (E2) embryos (confocal
(C) Percentage of rabbit embryos with 0, 1, 2, 3, or >3 HuN+ cells at 1–
IR7.1-TL2i cells (n = 114).
(D) Percentage of rabbit embryos with HuN+/SOX2+, HuN+/NANOG+, Hu
3 DIV after injection of cR-NCRM2-t2iLGöY and IR7.1-TL2i cells.
(E) Percentage of HuN+/SOX2+, HuN+/NANOG+, HuN+/OCT4+, HuN+/GAT
after injection of cR-NCRM2-t2iLGöY and IR7.1-TL2i cells.
(F) Percentage of rabbit embryos with 0, 1, 2, 3, or >3 HuN+ cells at 3
and IR7.1-TL2i-BCL2i cells (+/ Dox).
(G) Left panel: percentage of rabbit embryos with HuN+/SOX2+, HuN
NCRM2-t2iLGöY-BCL2i and IR7.1-TL2i-BCL2i cells (+/ Dox); right p
HuN+/GATA6+ cells at 3 DIV after injection of cR-NCRM2-t2iLGöY-BCL
(H) Immunostaining of HuN, SOX2, NANOG, and GATA6 in late blasto
NCRM2-t2iLGöY-BCL2i cells into morula-stage (E2) embryos (confocal
(I) Immunostaining of HuN, SOX2, NANOG, and GATA6 in late blastoc
TL2i-BCL2i cells into morula-stage (E2) embryos (confocal imaging).
66 Stem Cell Reports j Vol. 16 j 56–74 j January 12, 2021bryos had incorporated rhesus TL2i cells, for a total of 3
GFP+ cells (1 and 2 GFP+ cells/embryo), none of which
were either OCT4+ or NANOG+ (Figure 5C; Table S1). These
results indicate that human iPSCs (IR1.7-TL2i and cR-
NCRM2-t2iLGöY) and rhesus monkey PSCs (LyonES-
tGFP-(S3)-TL2i) show similar behaviors after injection
into closely and distantly related embryos (cynomolgus
and rabbit embryos, respectively).Contrasting Cell-Cycle Parameters of mESCs, and
Rhesus and Human Naive PSCs
To understand why rhesus and human PSCs stop multi-
plying when injected into host embryos, we examined
both the DNA replication and cell-cycle distribution. We
started by examining the incorporation of EdU as a mea-
sure of the fraction of cells that replicate in the cell pop-
ulation (% EdU+). Measurements were performed in
adherent cells (‘‘Adh’’), after single-cell dissociation with
trypsin (‘‘0h’’), and after re-incubation for 1 h (‘‘1h’’)
and 2 h (‘‘2h,’’ human cells only) at 37C in order to
mimic the conditions encountered by the cells during in-
jection into host embryos. mESCs incorporated EdU very
rapidly (Figure 6A), consistent with previous results
describing the high rate of 5-bromo-2-deoxyuridine incor-
poration in mESCs (Savatier et al., 1996). Single-cell disso-
ciation did not alter the percentage of EdU+ mESCs (77%
and 78% of EdU+ cells in Adh and 0h cells, respectively).
It slightly decreased in 1h cells (48% of EdU+ cells); how-
ever, the rate of EdU incorporation remained unchanged.
These observations suggest that DNA replication is not
altered by the experimental setting in the vast majority
of mESCs. Similar conclusions were made with mESCs
cultured in 2i/LIF medium. However, it should be notedA in late blastocyst-stage rabbit embryos (E5, 3 DIV) after micro-
(confocal imaging). Scale bars, 50 mm.
in late blastocyst-stage rabbit embryos (E5, 3 DIV) after microin-
imaging). Scale bars, 50 mm.
3 days (1–3 DIV) after injection of cR-NCRM2-t2iLGöY (n = 191) and
N+/GATA6+, HuN+/SOX17+, HuN+/T-BRA+, and HuN+/NESTIN+ cells at
A6+, HuN+/SOX17+, HuN+/T-BRA+, and HuN+/NESTIN+ cells at 3 DIV
days (3 DIV) after injection of cR-NCRM2-t2iLGöY-BCL2i (+/ Dox)
+/NANOG+, and HuN+/GATA6+ cells at 3 DIV after injection of cR-
anel: percentage of HuN+/EdU+, HuN+/SOX2+, HuN+/NANOG+, and
2i and IR7.1-TL2i-BCL2i cells (+/ Dox).
cyst-stage rabbit embryos (E5, 3 DIV) after microinjection of cR-
imaging). Scale bars, 50 mm.
yst-stage rabbit embryos (E5, 3 DIV) after microinjection of IR7.1-




Figure 5. Colonization of Cynomolgus Monkey Embryos by Human iPSCs and Rhesus PSCs
(A) Immunolabeling of GFP, OCT4, and NANOG in late blastocyst-stage cynomolgus embryos (E7) after microinjection of human cR-NCRM2-
t2iLGöY cells.
(B) Immunolabeling of GFP, OCT4, and NANOG in late blastocyst-stage cynomolgus embryos (E7) after microinjection of human IR7.1-TL2i
cells.
(C) Immunolabeling of GFP, OCT4, and NANOG in late blastocyst-stage cynomolgus embryos (E7) after microinjection of rhesus TL2i cells.
(A–C) Confocal imaging. Scale bars, 50 mm.that the rate of EdU incorporation was lower under 2i/LIF
culture conditions compared with that under serum/LIF
conditions. This finding is consistent with those of a pre-
vious report showing that mESCs cultured in 2i/LIFexhibit a slower cell cycle compared with their serum/
LIF counterparts (Ter Huurne et al., 2017).
The pattern of EdU incorporation in primed LyonES-
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EdU+ cells and the incorporation rate were significantly
reduced in Adh cells compared with those measured in
mESCs (Figure 6A). They were further reduced in 0h and
1h cells. In 1h cells, DNA replication was almost
completely abolished. This reveals the inherent failure of
primed LyonES-tGFP-(S3) cells to sustain cell-cycle progres-
sion following single-cell dissociation. Interestingly, re-
programming primed LyonES-tGFP-(S3) cells with 4i/L/b,
TL2i, and t2iLGöYprotocols significantly increased the per-
centage of EdU+ cells, consistent with a previous report
indicating that resetting naive-like features accelerated
the cell cycle of human PSCs (Chen et al., 2015a). However,
unlike mESCs, rhesus naive 4i/L/b, TL2i, and t2iLGöY cells
slowed DNA replication after dissociation, demonstrated
by a significant reduction of EdU incorporation in both
0h and 1h cells. In 1h cells, only 6%, 10%, and 18% of
the 4i/L/b, TL2i, and t2iLGöY cells, respectively, incorpo-
rated EdU (compared with 48% of mESCs under the same
experimental conditions). Furthermore, the incorporation
rate was considerably reduced as compared with Adh 4i/L/
b, TL2i, and t2iLGöY cells and 1h control mESCs. Overall,
these results indicate that rhesus naive PSCs, unlikemESCs,
fail to maintain active DNA replication in this experi-
mental setting. In addition, the cell-cycle distribution of
the 1h samples showed a slight increase in the proportion
of cells in the G1 phase at the expense of cells in the G2
phase in rhesus primed, 4i/L/b, TL2i, and t2iLGöY cells,
suggesting that some cells have already undergone growth
arrest in G1 phase. This alteration was not observed in
mESCs (Figure S5A). Taken together, these results indicate
that the vast majority of naive rhesus cells are markedly
slowed in their mitotic cycle at the time they are injected
into host embryos, or shortly after.
Similar results were obtained using human IR1.7-TL2i
and cR-NCRM2-t2iLGöY cells in the Adh, 0h, and 1h
conditions. A 2h condition (i.e., culture in suspension
for 2 h) was added to the experimental scheme. The per-
centage of EdU+ cells was reduced under the 0h, 1h, and
2h cells compared with the findings in Adh cells (Fig-
ure 6B). In 2h cells, only 15.2% of the IR1.7-TL2i cells
incorporated EdU (compared with 43.8% in Adh IR1.7-
TL2i cells, 2.5% in primed cells, and 58.1% in 2h mESCs).
The impact of suspension culture was less pronounced in
human cR-NCRM2-t2iLGöY cells. However, the rate ofFigure 6. Cell-Cycle Parameters of Mouse ESCs, Rhesus PSCs, and
(A) Flow cytometry analysis of EdU incorporation and propidium iod
(primed, 4i/L/b, TL2i, and t2iLGöY) in Adh, 0h, and 1h conditions. N
(B) Flow cytometry analysis of EdU incorporation and PI staining of m
IR7.1-TL2i) in Adh, 0h, 1h, and 2h conditions. Numbers indicate perce
EdU+, G1, and S/G2 cells).
(C) Western blot analysis of cell-cycle regulators in mESCs (serum/LIF
Adh, 0h, 1h, and 2h conditions (results of three experiments).EdU incorporation was significantly lower in cR-
NCRM2-t2iLGöY cells than in IR1.7-TL2i cells. Interest-
ingly, human cR-NCRM2-t2iLGöY cells exhibited a
unique pattern of EdU incorporation, in which the per-
centage of EdU+ cells was higher at 2h (27%) than at
0h (21.5%). This observation suggests that some cells in
the human cR-NCRM2-t2iLGöY population may have
the capacity to recover from the deleterious effects of sin-
gle-cell dissociation and gradually re-engage in the
mitotic cycle. This phenomenon was not observed in
any other cell lines. We also analyzed the cell-cycle distri-
bution (Figures 6B and S5B). In all human cells (primed,
IR1.7-TL2i and cR-NCRM2-t2iLGöY), the cell-cycle distri-
bution of the 2h samples exhibited an increased propor-
tion of cells in G1 phase at the expense of cells in S and
G2 phases, suggesting that some cells have already under-
gone growth arrest in G1 phase. This alteration was not
observed in mESCs, further indicating that only mESCs
retain the capacity to actively divide in non-adherent cul-
ture conditions.
To understand why the mitotic cycle is slowed in hu-
man naive PSCs after single-cell dissociation, we studied
the expression of cell-cycle regulators, including CDK2,
CDK4, CYCLIN D1, D2, D3, E, and A, and the CDK inhib-
itor p27Kip1 (Figures 6C and S5C). No differences of CDK2
and CDK4 levels were observed among Adh, 0h, 1h, and
2h samples in all cell types analyzed. In mESCs, the levels
of CYCLIN E and A were increased. CYCLIN D1, CYCLIN
D2, and p27Kip1 were not expressed as reported previously
(Savatier et al., 1996) (Stead et al., 2002). In human
primed PSCs, the expression of CYCLIN D1, D2, and D3
was decreased and that of p27Kip1 was increased after
dissociation and suspension culture. In cR-NCRM2-t2iL-
GöY cells, the expression of CYCLIN D1, D2, D3, and A
was decreased, and that of p27Kip1 was increased. In
IR1.7-TL2i cells, the expression of CYCLIN D2 and A
was decreased, and that of p27Kip1 was increased. There-
fore, single-cell dissociation followed by suspension cul-
ture triggers opposite responses in mESCs and human
naive PSCs. In mESCs, it activates the expression of posi-
tive regulators of the mitotic cycle, whereas in human
naive PSCs it reduces their levels, and concomitantly in-
creases that of a negative regulator. These results are
consistent with the results of EdU incorporation andHuman iPSCs, before and after Reprogramming to Naive States
ide (PI) staining of mESCs (serum/LIF and 2i/LIF) and rhesus PSCs
umbers indicate percentages of EdU+ cells.
ESCs (serum/LIF) and human iPSCs (primed, cR-NCRM2-t2iLGöY and
ntages of EdU+ cells. Histograms show the cell-cycle distribution (%
) and human iPSCs (primed, cR-NCRM2-t2iLGöY and IR1.7-TL2i) in
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cytometry analyses, revealing cell-cycle delay, and
possibly growth arrest in G1 phase.
Rhesus PSCs Stall in the G1 Phase after Transfer into
Rabbit Embryos
We observed that mESCs continue to actively replicate
their DNA after injection into rabbit embryos (Figure 1C).
Therefore, we investigated whether naive rhesus cells
that survive injection and successfully colonize the
ICM/epiblast retain a high proliferative capacity. For
this purpose, ten rhesus TL2i cells were injected into rab-
bit embryos at the morula stage. The embryos were sub-
sequently cultured for 1 and 2 DIV before pulse labeling
with EdU. At 1 DIV, seven embryos had GFP+ cells in the
ICM/epiblast (37%, n = 19) for a total of 29 GFP+ cells.
Triple immunostaining for GFP, SOX2, and EdU showed
that 24 (82%) of these 29 GFP+ cells expressed SOX2, of
which only four had incorporated EdU (Figure S6). At 2
DIV, nine embryos had GFP+ cells in the ICM/epiblast
(60%, n = 15) for a total of 61 GFP+ cells. Of these 61
GFP+ cells, 44 (72%) expressed SOX2, and 1 incorporated
EdU (2%). These results reveal that the rhesus naive cells
that survived and colonized the rabbit embryos retarded
their DNA replication and potentially underwent growth
arrest.
To obtain further insight into the cell cycle of
the mESCs and rhesus 4i/L/b, TL2i, and t2iLGöY naive
PSCs after injection into rabbit embryos, we generated
cell lines expressing the FUCCI(CA) reporter system
(Sakaue-Sawano et al., 2017). The mESCs expressing PB-
PuroR- CAG-mVenus:hGeminin-IRES-mCherry:hCdt1, herein-
after referred to as mESC-FUCCI(CA), exhibited a cell-cycle
distribution typical of mESCs (18%, 69%, and 11% of cells
in G1, S, and G2 phases, respectively; Figures S7A and S7B).
On the other hand, rhesus PSC-FUCCI(CA) cells exhibited
an extended G1 phase relative to other cell-cycle phases
(43%, 36%, and 13% of the cells in G1, S, and G2 phases,
respectively) (Figures S7C and S7D). After injection into
rabbit embryos, mESC-FUCCI(CA) cells proliferated
actively during the 3 DIV, as shown by the expansion of
themVENUS+ cell population identified through immuno-
staining with an anti-mVENUS antibody (green) in 100%
of the embryos (Figures 7A and 7B). Even after 3 DIV,
mCHERRY+ cells (red), identified using an anti-mCHERRY
antibody, and mVENUS+/mCHERRY+ cells (yellow), were
proportionally less numerous, indicating that only rare
mESCswere in G1 andG2 phases, respectively. In addition,Figure 7. Cell-Cycle Distribution of Mouse and Rhesus PSCs after
(A) Phase contrast and epifluorescence imaging of mouse ESCs and rh
cycle reporter system. Immunostaining of mVenus and mCherry in rab
mouse and rhesus PSCs into morula-stage (E2) embryos (confocal im
(B) Histogram of the percentage of rabbit embryos having cells in G1at all time points analyzed, there were no embryos contain-
ing only mCHERRY+ (red) cells (n = 27) (Figure 7B). These
results indicate that mESCs continue to proliferate actively
for at least 3 days after injection into host embryos, in line
with the EdU incorporation data.
On the other hand, the cell-cycle distribution of rhesus
PSC-FUCCI(CA) cells after injection into rabbit embryos
was clearly different, regardless of the method used (4i/L/
b, TL2i, and t2iLGöY) for reprogramming to the naive state.
At 1 DIV, the majority of embryos contained only
mCHERRY+ (red) cells (t2iLGöY, 60%, n = 47; TL2i, 68%,
n = 11; 4i/L/b, 60%, n = 25). The remaining embryos con-
tained both mVENUS+ (green) and mVENUS+/mCHERRY+
(yellow) cells in addition to mCHERRY+ (red) cells. In
embryos injected with TL2i and 4i/L/b cells, the rate of
embryos containing only mCHERRY+ (red) cells increased
over time in culture, reaching 78% (n = 9) and 100%
(n = 3) with 4i/L/b and TL2i cells, respectively, at 3 DIV
(Figure 7B). In embryos injected with t2iLGöY cells, the
proportion of embryos containing only mCHERRY+ (red)
cells first decreased at 2DIV (35%, n = 36) and subsequently
increased at 3 DIV (95%, n = 35) (Figure 7B). These results
indicate that most naive rhesus PSC-FUCCI(CA) cells accu-
mulate in the G1 phase of the cell cycle after injection into
rabbit embryos.DISCUSSION
In our study, we aimed to understand why human naive
PSCs failed to colonize mouse and pig embryos (Masaki
et al., 2015; Theunissen et al., 2016; Wu et al., 2017),
despite exhibiting characteristic features of naive pluripo-
tency as primarily defined in rodents. Ourmain conclusion
is that human and NHP naive PSCs are inherently unfit to
remain mitotically active during embryo colonization and
therefore differentiate prematurely.
The first question we addressed was whether or not host
embryos are permissive to colonization by naive PSCs. To
answer this question, we injected mouse ESCs into rabbit
and cynomolgus embryos and showed that they continue
to express pluripotency markers, they remain mitotically
active for at least 3 DIV, and they contributed to the expan-
sion of the host epiblast. Some of them contributed to the
formation of the neural tube in rabbit post-implantation
embryos. We conclude that the ICM and epiblast of rabbit
and cynomolgus embryos are permissive to colonizationInjection into Rabbit Embryos
esus TL2i, 4i/L/b, and t2iLGöY PSCs expressing the FUCCI(CA) cell-
bit embryos 1–3 days (1–3 DIV) after microinjection of FUCCI(CA)
aging). Scale bars, 50 mm.
, S, and G2 phases of the cell cycle at 1, 2, and 3 DIV (n = 220).
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by bona fide naive PSCs. These results may seem to contra-
dict those of Wu et al. (2017), who injected mouse
ESCs into pig embryos and observed no chimerism at
days 21–28 of gestation. Differentiated cells derived from
mouse ESCs are likely to disappear from the chimera
through cell competition in later stages of development;
however, this should not obscure the fact that the mouse
ESCs are initially capable of colonizing pre-implantation
embryos very efficiently.
In sharp contrast with mESCs, none of the naive rhesus
and human PSCs tested in the same experimental para-
digm is capable of massively colonizing the ICM and
epiblast of the host, whether rabbit or cynomolgusmonkey
embryos. Some cells retaining the expression of pluripo-
tency markers were observed at 3 DIV in rabbit embryos af-
ter injection of LCDM (EPS) (9% of total embryos), 4i/L/b
(2% of total embryos), TL2i (5% of total embryos), TL-
CDK8/19i (2% of total embryos), and t2iLGöY PSCs (3%
of total embryos) (Table S1). In these 234 chimeric em-
bryos, the total number of GFP+ cells expressing pluripo-
tency markers after 3 DIV was 3.26 ± 1.27, when 10 cells
were injected at the morula stage. The other cells differen-
tiated prematurely. In contrast, up to 40 GFP+/NANOG+
and 36 GFP+/SOX2+ cells/embryo were observed following
injection of 10 mESCs into rabbit morulas after the same
period of culture. Similarly, up to 23 GFP+/SOX2+ cells/em-
bryo were observed after injection of mESC-2i/LIF cells.
These results illustrate the striking difference observed be-
tween mouse ESCs and primate naive PSCs in the stability
of pluripotency gene expression after injection into host
embryos. As a result, none of the protocols tested confer
an embryo colonization competence to primate naive
PSCs similar to that of mESCs. It should be noted, however,
that the different protocols tested for reprogramming hu-
man and NHP PSCs did not yield identical results. We
were unable to generate undeniable chimeric blastocysts
with the E-NHSM and NHSM-v protocols. This result is in
contradiction with a previous publication reporting effi-
cient colonization of cynomolgus monkey embryos by
PSCs reprogrammed using the NHSM-v protocol (Chen
et al., 2015b). This difference can be explained by the im-
munodetection of GFP+ cells in the developing embryos,
which eliminates the confounding effect of autofluores-
cence due to dying and necrotic cells. We did not observe
significant differences in the rate of colonization by
GFP+/NANOG+, GFP+/OCT4+, and SOX2+/GFP+ cells be-
tween the other five reprogramming protocols. We do
not rule out the possibility that some of these protocols
may be more effective than others in generating cells
capable of colonization. However, the number of unques-
tionable chimeric blastocysts obtained with each of these
protocols was insufficient to conclude about significant
differences.72 Stem Cell Reports j Vol. 16 j 56–74 j January 12, 2021After injection into rabbit and macaque monkey mor-
ulas, most rhesus and human naive PSCs undergo cell
death. We showed that the few cells that survive after 3
DIV stall in the G1 phase and commit to differentiation,
demonstrated by the loss of pluripotency markers (OCT4,
SOX2, and NANOG) and the activation of differentiation
markers (GATA6, SOX17, and T-BRA). Cell death can be
prevented by overexpressing BCL2, leading to an apparent
increase in the rate of colonization by donor cells. Howev-
er, the proportion of pluripotent cells remains globally un-
changed, indicating that the prevention of cell death does
not prevent the premature differentiation observed with
BCL2 transgene expression-negative cells. The behavior of
primate naive PSCs is in sharp contrast with that of mESCs,
which continue to actively proliferate after injection into
host embryos. These results reveal the inability of human
and rhesusmonkey naive PSCs to remainmitotically active
in an unfavorable environment and question their very na-
ture. Despite requiring complex culturemedia, human and
NHP naive PSCs self-renew in a more precarious equilib-
rium than mESCs. This suggests a much higher sensitivity
to alterations of their local environment, possibly explain-
ing the poor performance of human and rhesus monkey
naive PSCs in colonizing the epiblast of host embryos. As
a matter of fact, disruption of the human and rhesus PSC
cell cycle is already demonstrated immediately after the
colony dissociation (i.e., before embryo injection) where
most naive PSCs cells undergo a drastic slowdown in
DNA replication. Mitotic arrest is associated with downre-
gulation of CYCLIN expression and an upregulation of
p27Kip1 expression. We speculate that only few cells retain
the capacity to actively divide and re-enter the next divi-
sion cycle when introduced into the embryo environment.
In the prospect of generating interspecies chimeras, an
equally important issue is the influence of the host spe-
cies on the rate of colonization. Rhesus and human
PSCs (TL2i and t2iLGöY reprogramming protocols) did
not show a marked difference in survival rate and stabil-
ity of pluripotency gene expression after injection into
rabbit and cynomolgus embryos. Similarly, mouse ESCs
were able to colonize both rabbit and cynomolgus em-
bryos with high efficiency. This suggests that the rabbit
embryo is a valuable model system for exploring further
improvements.EXPERIMENTAL PROCEDURES
Cell Lines, Media Composition, and Culture
Primed-to-naive conversion was performed using previously
described protocols, including E-NHSM (https://hannalabweb.
weizmann.ac.il) (Gafni et al., 2013), NHSM-v (Chen et al.,
2015b), 4i/L/b (Fang et al., 2014), 5iL/A (Theunissen et al., 2014),
t2iLGöY (Guo et al., 2017), TL2i (Chen et al., 2015a), TL-CDK8/
19i (modified from Lynch et al., 2020), and LCDM (EPS) (Yang
et al., 2017a). Detailed protocols are provided in the Supplemental
Experimental Procedure.ETHICS
All procedures in macaque monkeys were approved by the
French ethics committee CELYNE (approval no.: APA-
FIS#4858). All animal procedures in rabbits were approved
by the French ethics committee CELYNE (APAFIS#6438).
Chimera experiments involving human iPSCs were
approved by the INSERM ethics committee.
RNA Sequencing
RNA from cell lines was extracted and libraries were pre-
pared using 200 ng of RNA with the NextFlex Rapid Direc-
tional mRNA-Seq kit (Bioo-Scientific). Samples were
sequenced on a NextSeq500 sequencing machine (Illu-
mina) as single reads of 75 bp. Detailed protocols are pro-
vided in Supplemental Experimental Procedure.
Data and Code Availability
The RNA sequencing datasets generated during this study
are available under GEO accession number GSE146178.
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Supplemental Information can be found online at https://doi.org/
10.1016/j.stemcr.2020.12.004.
AUTHOR CONTRIBUTIONS
I.A., C.R., A.M., E.M., V.C., A.B.-M., N.D., F.W., P.-Y.B., and M.A.
performed cell and embryo cultures and cell characterizations.
M.D. and T.J. performed animal surgery. G.M., C.M., and O.R. per-
formed bioinformatic analyses. C.L., M.S., and C.D. shared unpub-
lished expertise. I.A. and P.S. analyzed the data and wrote the
manuscript.
ACKNOWLEDGMENTS
We are grateful to all members of the animal facility team for their
work and dedication, and to Charlotte Bréhier for technical help
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